| Drugs affecting bone metabolism |
Prescribing Data Report |
August 2021 |
| Fast acting insulin lispro for the treatment of diabetes mellitus |
New Drug Evaluations |
February 2021 |
| Drugs used in Diabetes |
Prescribing Data Report |
January 2022 |
| Cardiovascular outcomes associated with SGLT2 inhibitors (update 2) |
Medicines in Practice |
December 2020 |
| Cardiovascular outcomes associated with GLP1 receptor agonists (updated) |
Medicines in Practice |
November 2020 |
| Flash glucose monitoring prescribing update – Freestyle Libre |
Prescribing for Population Health |
October 2020 |
| Oral semaglutide for the treatment of type 2 diabetes mellitus |
New Drug Evaluations |
October 2020 |
| Comparison of GLP 1 Agonists (update November 2020) |
Prescriber Support Tools |
November 2020 |
| Comparison of SGLT2 inhibitors (update) |
Prescriber Support Tools |
February 2020 |
| Insulin glargine plus lixisenatide (Suliqua) for the treatment of T2DM |
New Drug Evaluations |
August 2019 |
